Release, Amnesty International, UNJUST UK, HRI and IDPC shed light on racial disparities in drug policing and associated human rights violations, urging for decriminalisation, the redirection of resources into care systems, and equitable reform.
Allen et al. reveal the value of community interventions to prevent HIV outbreaks, highlighting the potential for scaled-up services for communities of people who use drugs to avert outbreaks.
HRI highlight how underinvestment in harm reduction in low- and middle-income countries hinders progress towards global health goals, whilst costly punitive drug policies prevail.
APCOM and IDPC urge the public, law enforcement, and policymakers in Thailand to help ensure equality and equity for LGBTQ+ people who use drugs, especially in their access to health and social services, and ending stigma and discrimination against them.
UNODC provide an update on global drug markets, trends, and policy developments – including, for the first time, a chapter on the right to health and drug use.
The HIV Legal Network identifies what can and needs to be done to strengthen the response to HIV, other STBBIs, and other health concerns among GBT2Q people who use drugs.
The EMCDDA reports on high availability and potency of substances, increasingly sophisticated supply infrastructures and the involvement and exploitation of people in situations of vulnerability in informal markets.
The Parabola Center finds that most Americans prioritise social equity in cannabis regulation, trusting communities with lived-experience and people who use marijuana to craft fair cannabis policy.
Fonseca et al. document no difference on cognitive function between non-users and long-term drinkers of ayahuasca, a substance with psychedelic properties.
